Dergi makalesi Açık Erişim
Senol, Sefika Pinar; Temiz-Resitoglu, Meryem; Guden, Demet Sinem; Sari, Ayse Nihal; Sahan-Firat, Seyhan; Tunctan, Bahar
{ "conceptrecid": "231629", "created": "2022-10-07T08:13:22.731071+00:00", "doi": "10.1007/s11064-020-03197-7", "files": [ { "bucket": "31091a07-a1db-4870-a9f0-d887bd86c852", "checksum": "md5:c8504042ab65859f0c21a6062d797169", "key": "bib-dfbae190-d51c-4a2a-a17e-980988c4347e.txt", "links": { "self": "https://aperta.ulakbim.gov.tr/api/files/31091a07-a1db-4870-a9f0-d887bd86c852/bib-dfbae190-d51c-4a2a-a17e-980988c4347e.txt" }, "size": 340, "type": "txt" } ], "id": 231630, "links": { "badge": "https://aperta.ulakbim.gov.tr/badge/doi/10.1007/s11064-020-03197-7.svg", "bucket": "https://aperta.ulakbim.gov.tr/api/files/31091a07-a1db-4870-a9f0-d887bd86c852", "doi": "https://doi.org/10.1007/s11064-020-03197-7", "html": "https://aperta.ulakbim.gov.tr/record/231630", "latest": "https://aperta.ulakbim.gov.tr/api/records/231630", "latest_html": "https://aperta.ulakbim.gov.tr/record/231630" }, "metadata": { "access_right": "open", "access_right_category": "success", "communities": [ { "id": "tubitak-destekli-proje-yayinlari" } ], "creators": [ { "affiliation": "Mersin Univ, Dept Pharmacol, Fac Pharm, Mersin, Turkey", "name": "Senol, Sefika Pinar" }, { "affiliation": "Mersin Univ, Dept Pharmacol, Fac Pharm, Mersin, Turkey", "name": "Temiz-Resitoglu, Meryem" }, { "affiliation": "Mersin Univ, Dept Pharmacol, Fac Pharm, Mersin, Turkey", "name": "Guden, Demet Sinem" }, { "affiliation": "Mersin Univ, Dept Pharmacol, Fac Pharm, Mersin, Turkey", "name": "Sari, Ayse Nihal" }, { "affiliation": "Mersin Univ, Dept Pharmacol, Fac Pharm, Mersin, Turkey", "name": "Sahan-Firat, Seyhan" }, { "affiliation": "Mersin Univ, Dept Pharmacol, Fac Pharm, Mersin, Turkey", "name": "Tunctan, Bahar" } ], "description": "A selective RXR agonist, bexarotene, has been shown to have anti-inflammatory, anti-nociceptive, and neuroprotective effects in several models of numerous neurological diseases characterized by systemic inflammation. The mechanisms underlying these effects remains unknown. To elucidate these mechanisms, we investigated whether the TLR4/MyD88/TAK1/NF-kappa B/COX-2 signaling pathway in the CNS mediates the effect of bexarotene to prevent hyperalgesia in the LPS-induced inflammatory pain mouse model. The reaction time to thermal stimuli within 30 s was evaluated by the hot plate test in male mice treated with saline, LPS (10 mg/kg), DMSO, and/or bexarotene (0.1, 1, 3, or 10 mg/kg) after 6 h. The latency to the thermal stimulus (18.11 +/- 1.36 s) in the LPS-treated mice was significantly decreased by 30% compared with saline-treated mice (25.84 +/- 1.99 s). Treatment with bexarotene only at a dose of 10 mg/kg showed a significant increase in the latency by 22.49 +/- 1.00 s compared with LPS-treated mice. Bexarotene also prevented the reduction in RXR alpha protein expression associated with a rise in the expression of TLR4, MyD88, phosphorylated TAK1, NF-kappa B p65, phosphorylated NF-kappa B p65, COX-2, and IL-1 beta proteins, in addition to COX-2 activity and levels of PGE(2) and IL-1 beta in the brains and spinal cords of the LPS-treated animals. Likely, decreased activity of TLR4/MyD88/TAK1/NF-kappa B/COX-2 signaling pathway in addition to increased pro-inflammatory cytokine formation in the CNS of mice participates in the protective effect of bexarotene against hyperalgesia induced by LPS.", "doi": "10.1007/s11064-020-03197-7", "has_grant": false, "journal": { "issue": "3", "pages": "624-637", "title": "NEUROCHEMICAL RESEARCH", "volume": "46" }, "license": { "id": "cc-by" }, "publication_date": "2021-01-01", "relations": { "version": [ { "count": 1, "index": 0, "is_last": true, "last_child": { "pid_type": "recid", "pid_value": "231630" }, "parent": { "pid_type": "recid", "pid_value": "231629" } } ] }, "resource_type": { "subtype": "article", "title": "Dergi makalesi", "type": "publication" }, "science_branches": [ "Di\u011fer" ], "title": "Suppression of TLR4/MyD88/TAK1/NF-kappa B/COX-2 Signaling Pathway in the Central Nervous System by Bexarotene, a Selective RXR Agonist, Prevents Hyperalgesia in the Lipopolysaccharide-Induced Pain Mouse Model" }, "owners": [ 1 ], "revision": 1, "stats": { "downloads": 10.0, "unique_downloads": 10.0, "unique_views": 22.0, "version_downloads": 10.0, "version_unique_downloads": 10.0, "version_unique_views": 22.0, "version_views": 23.0, "version_volume": 3400.0, "views": 23.0, "volume": 3400.0 }, "updated": "2022-10-07T08:13:22.779525+00:00" }
Görüntülenme | 23 |
İndirme | 10 |
Veri hacmi | 3.4 kB |
Tekil görüntülenme | 22 |
Tekil indirme | 10 |